<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for Cobra Biomanufacturing - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/cab/cab000.html</link>
    <description>Cobra Biomanufacturing news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 21 Nov 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 21 Nov 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>Productions of Sars protein in CHO cells</title>
      <description>Cobra Biomanufacturing has entered into a manufacturing agreement with an undisclosed pharmaceutical company to produce a protein from the Sars virus in CHO (Chinese Hamster Ovary) cells under cGMP</description>
      <pubDate>Fri, 29 Feb 2008 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab118.html</link>
    </item>
    <item>
      <title>Prize for ubiquitous chromatin-opening element</title>
      <description>Presentation on UCOE protein expression technology was awarded the best oral presentation at the 18th Esact-UK scientific meeting, which took place in Cambridge in January 2008</description>
      <pubDate>Wed, 20 Feb 2008 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab117.html</link>
    </item>
    <item>
      <title>Manufacturing agreement for TNFerade</title>
      <description>Cobra Biomanufacturing has entered into a manufacturing development agreement with GenVec for TNFerade, GenVec's lead product candidate</description>
      <pubDate>Mon, 28 Jan 2008 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab116.html</link>
    </item>
    <item>
      <title>Cobra joins consortium to develop oral vaccines</title>
      <description>UK-based Cobra Biomanufacturing announces its involvement in a consortium formed to develop a new vaccine delivery system based on live bacterial spores</description>
      <pubDate>Mon, 12 Mar 2007 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab115.html</link>
    </item>
    <item>
      <title>Manufacturing agreement with Pharmexa</title>
      <description>UK-based Cobra Biomanufacturing announces an agreement with Pharmexa for the manufacture of the protein vaccine PX107 for use in Phase I clinical trials for bone disorders</description>
      <pubDate>Mon, 05 Feb 2007 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab113.html</link>
    </item>
    <item>
      <title>Cobra's new general manager for Oxford facility</title>
      <description>Cobra Biomanufacturing has announced that it has appointed Tony Mulcahy as general manager, Oxford Facility</description>
      <pubDate>Mon, 05 Feb 2007 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab114.html</link>
    </item>
    <item>
      <title>Cequent to evaluate Cobra ORT Technology for RNAi</title>
      <description>Cobra Biomanufacturing has signed an agreement with Cequent Pharmaceuticals to develop a treatment for an inherited form of bowel tumour (familial adenomatous polyposis, FAP)</description>
      <pubDate>Mon, 22 Jan 2007 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab112.html</link>
    </item>
    <item>
      <title>Agreement to evaluate oral vaccine delivery</title>
      <description>Cobra signs deal with the Naval Medical Research Center of the US Navy to construct and test a vaccine against malaria using Cobra's proprietary Ort-Vac oral vaccine delivery technology</description>
      <pubDate>Wed, 18 Oct 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab111.html</link>
    </item>
    <item>
      <title>Cobra to support novel gene therapy trials</title>
      <description>UK based Cobra Biomanufacturing has announced an agreement with the Italian Telethon Foundation to manufacture plasmids for two innovative gene therapy trials</description>
      <pubDate>Wed, 13 Sep 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab110.html</link>
    </item>
    <item>
      <title>Cobra strengthens management team</title>
      <description>Cobra Biomanufacturing announces the appointment of John Lovelady as director of manufacturing operations for the group</description>
      <pubDate>Thu, 24 Aug 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab109.html</link>
    </item>
    <item>
      <title>Cobra extends agreement to manufacture AA4500</title>
      <description>Cobra Biomanufacturing and Auxilium Pharmaceuticals have announced an important contract to produce further cGMP batches and three BLA (Biologics Licence Application) batches of AA4500</description>
      <pubDate>Wed, 19 Jul 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab108.html</link>
    </item>
    <item>
      <title>Cobra granted two European patents</title>
      <description>Cobra Biomanufacturing announces the award of two European patents, further strengthening its patent portfolio in the area of plasmid DNA manufacture</description>
      <pubDate>Tue, 20 Jun 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab107.html</link>
    </item>
    <item>
      <title>Manufacturing deal with Aids Vaccine Initiative</title>
      <description>Cobra Biomanufacturing in agreement with the International Aids Vaccine Initiative (IAVI) and GlaxoSmithKline Biologicals for process development and manufacturing of two HIV vaccine candidates</description>
      <pubDate>Wed, 03 May 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab106.html</link>
    </item>
    <item>
      <title>Tool for inserting genes into bacteria</title>
      <description>Xer-cise was developed in Cobra's research laboratories over several years and enables genes to be switched in and out of bacterial chromosomal DNA cleanly and more efficiently than current methods</description>
      <pubDate>Tue, 11 Apr 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab105.html</link>
    </item>
    <item>
      <title>Strategic US east coast appointment</title>
      <description>Cobra Biomanufacturing announces the appointment of Andrew Arrage as vice president, business development for the eastern US region</description>
      <pubDate>Tue, 04 Apr 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab104.html</link>
    </item>
    <item>
      <title>Cobra in gene therapy deal with Replikun Biotech</title>
      <description>Cobra Biomanufacturing has signed a contract with the Australian company Replikun Biotech to support the development of an innovative gene therapy method.</description>
      <pubDate>Tue, 07 Mar 2006 08:00:00 UT</pubDate>
      <category>Cobra Biomanufacturing</category>
      <link>http://www.laboratorytalk.com/news/cab/cab102.html</link>
    </item>
  </channel>
</rss>
